2m 2m 2m 2m 2m 2m 2m
Vistagen Thera (VTGN)
NASDAQ
$0.24-$0.009 (-3.44%)
Price as of Jul 14, 2026 8:25 AM EDT- $10.4MMarket Cap
- -89.38%1-Year Change
- BiotechnologyIndustry
Vistagen Thera (VTGN)
$0.24-$0.009 (-3.44%)
VTGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.25 | ||
Change | -$0.005 (-2.05%) | ||
Open | $0.26 | ||
High | $0.26 | ||
Low | $0.25 | ||
Previous Close | $0.26 | ||
Volume | 1,428,722 | ||
30-Day Average Volume | 4,877,300 | ||
1-Week Change | 2.81% | ||
1-Month Change | -56.14% | ||
1-Year Change | -89.38% | ||
3-Year Change | -85.96% | ||
5-Year Change | -99.72% | ||
Fundamentals | |||
Shares Outstanding | 41.0M | ||
Total Assets | $48.6M | ||
Market Cap | $10.4M | ||
Enterprise Value | -$20.3M | ||
Period: QTR TTM FY | |||
Revenue | $464,000.00 | ||
Net Income | -$16.3M | ||
Free Cash Flow | -$16.2M | ||
EBIT | -$16.3M | ||
EBITDA | -$16.2M | ||
Net Working Capital | $34.1M | ||
EPS | -$0.38 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | -44 | ||
P/B | 0 | ||
P/E | -1 | ||
PEG | -0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 06/07/2023 | ||
Earnings & Revenue